Cargando…

Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma

BACKGROUND: Complement factor H-related 4 (CFHR4) is a protein-coding gene that plays an essential role in multiple diseases. However, the prognostic value of CFHR4 in hepatocellular carcinoma (HCC) is unknown. METHODS: Using multiple databases, we investigated CFHR4 expression levels in HCC and mul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Hongjun, Wang, Chaoqun, Ke, Shanjia, Bai, Miaoyu, Xu, Yanan, Lu, Shounan, Feng, Zhigang, Qian, Baolin, Xu, Yue, Zhou, Menghua, Li, Zihao, Yin, Bing, Li, Xinglong, Hua, Yongliang, Zhou, Yongzhi, Pan, Shangha, Fu, Yao, Ma, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257081/ https://www.ncbi.nlm.nih.gov/pubmed/35812416 http://dx.doi.org/10.3389/fimmu.2022.892750

Ejemplares similares

Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer
por: Qian, Baolin, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK/MAPK pathway
por: Xu, Yanan, et al.
Publicado: (2023)

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
por: Lu, Shounan, et al.
Publicado: (2022)

Integrative Analysis of the Roles of lncRNAs and mRNAs in Itaconate-Mediated Protection Against Liver Ischemia-Reperfusion Injury in Mice
por: Xu, Yanan, et al.
Publicado: (2021)

LncRNA Hnf4αos exacerbates liver ischemia/reperfusion injury in mice via Hnf4αos/Hnf4α duplex-mediated PGC1α suppression
por: Wang, Chaoqun, et al.
Publicado: (2022)

Comprehensive analysis of transcriptome‐wide M(6)A methylation for hepatic ischaemia reperfusion injury in mice
por: hua, yongliang, et al.
Publicado: (2023)

Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets
por: Bai, Miaoyu, et al.
Publicado: (2022)

TMEM147 aggravates the progression of HCC by modulating cholesterol homeostasis, suppressing ferroptosis, and promoting the M2 polarization of tumor-associated macrophages
por: Huang, Jingjing, et al.
Publicado: (2023)

Tumor-associated macrophages in cholangiocarcinoma: complex interplay and potential therapeutic target
por: Zhou, Menghua, et al.
Publicado: (2021)

Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)

Associations of CFH Polymorphisms and CFHR1-CFHR3 Deletion with Blood Pressure and Hypertension in Chinese Population
por: Gan, Wei, et al.
Publicado: (2012)

Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32
por: Holmes, Lucy V., et al.
Publicado: (2013)

CFHR1 is a potentially downregulated gene in lung adenocarcinoma
por: Wu, Geting, et al.
Publicado: (2019)

Novel CFHR2-CFHR1 Hybrid in C3 Glomerulopathy Identified by Genomic Structural Variation Analysis
por: Sugawara, Yuka, et al.
Publicado: (2019)

Atypical haemolytic uremic syndrome with refractory multiorgan involvement and heterozygous CFHR1/CFHR3 gene deletion
por: Diep, Jason, et al.
Publicado: (2023)

Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome
por: Zipfel, Peter F, et al.
Publicado: (2007)

The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi
por: Siegel, Corinna, et al.
Publicado: (2010)

Correction for: The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma
por: Wan, Zhongzhong, et al.
Publicado: (2022)

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration
por: Lorés-Motta, Laura, et al.
Publicado: (2021)

Regulating complement in the kidney: insights from CFHR5 nephropathy
por: Gale, Daniel P., et al.
Publicado: (2011)

Atypical HUS Associated with CFH/CFHR-1 Hybrid Gene
por: Negi, Sharon, et al.
Publicado: (2020)

Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017)

Sex differences in hepatic ischemia‒reperfusion injury: a cross-sectional study
por: Li, Zhongyu, et al.
Publicado: (2023)

Human Factor H-Related Protein 2 (CFHR2) Regulates Complement Activation
por: Eberhardt, Hannes U., et al.
Publicado: (2013)

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations
por: Kumar, Vikrant, et al.
Publicado: (2022)

Pathogenic Neisseria Bind the Complement Protein CFHR5 via Outer Membrane Porins
por: Yee, Wearn-Xin, et al.
Publicado: (2022)

CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023)

CFHR5 Nephropathy in a Greek-Cypriot Australian Family: Ancestry-Informed Precision Medicine
por: Ng, Monica S.Y., et al.
Publicado: (2018)

Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy
por: Guzzo, Gabriella, et al.
Publicado: (2021)

Atypical hemolytic uremic syndrome: Unique clinical presentation linked to rare CFHR5 mutation
por: Menotti, Sofia, et al.
Publicado: (2021)

Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration
por: Ansari, Morad, et al.
Publicado: (2013)

Association among Complement Factor H Autoantibodies, Deletions of CFHR, and the Risk of Atypical Hemolytic Uremic Syndrome
por: Jiang, Hong, et al.
Publicado: (2016)

Complement Factor H-Related Protein 4A Is the Dominant Circulating Splice Variant of CFHR4
por: Pouw, Richard B., et al.
Publicado: (2018)

CFH and CFHR Copy Number Variations in C3 Glomerulopathy and Immune Complex-Mediated Membranoproliferative Glomerulonephritis
por: Piras, Rossella, et al.
Publicado: (2021)

CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023)

Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration
por: Narendra, Umadevi, et al.
Publicado: (2009)

Acquired thrombotic thrombocytopenic purpura with isolated CFHR3/1 deletion—rapid remission following complement blockade
por: Bitzan, Martin, et al.
Publicado: (2018)

LncRNA MIAT enhances systemic lupus erythematosus by upregulating CFHR5 expression via miR-222 degradation
por: Zhang, Yali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uo9st6tntnibghcupm1jsl8v6j